As emerging markets open their doors to innovative healthcare technologies, Argentina is quickly becoming a top destination for MedTech expansion. In this post, we speak with Matias, Arazy Group’s Corporate Sales Manager and General Manager of the Argentine office, who shares what MedTech companies need to know about navigating regulatory access, choosing the right strategy,…
Lately, I’ve been reflecting on how often companies underestimate the complexity of global regulatory submissions. Everyone’s trying to move fast—but fast doesn’t always mean strategic. And honestly, it’s not the big, obvious challenges that cause trouble. The smaller, overlooked assumptions end up delaying launches or putting compliance at risk. After years of working with clients…
The Medical Device User Fee Amendments (MDUFA) have long been a defining feature of FDA operations, providing critical funding for regulatory processes. But do they genuinely serve the industry and public interest or introduce conflicts that could unintentionally shape the regulatory landscape? As regulatory professionals, we must ask: Are we optimizing the system for efficiency…
As artificial intelligence (AI) continues to reshape industries, we’re clearly on the brink of a profound transformation—not just in how businesses operate but in the nature of work itself. Traditional roles will evolve into something more dynamic, creative, and human-centric in this new era. This isn’t about replacing people with machines; it’s about empowering people…
The End of Software as We Know It Let me paint you a picture of what’s next. In the evolving landscape of technology, the need for traditional user interfaces is fading away. We’re standing at the edge of a revolution. AI agents are stepping up to assist and replace how we fundamentally interact with software….
Patient safety remains a cornerstone of the global medical device industry, and the European Union is taking significant steps to uphold this principle. With the introduction of Article 10a under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), manufacturers must proactively address potential supply interruptions that could jeopardize patient care. Effective January…
As the landscape of healthcare continues to evolve, trade fairs like Arab Health and Medica play pivotal roles in shaping the future of medical technology. Both events offer unique opportunities for networking, innovation, and business development. However, for small to medium-sized medical device companies, Arab Health may provide a more strategic advantage in the current…
Introduction The FDA’s most recent cybersecurity standards, effective March 2024, represent a major shift for regulatory professionals, particularly for those involved with AI-enabled medical devices, which introduce unique risks and complexities. These standards emphasize data security, device integrity, and patient safety, all crucial in today’s rapidly evolving AI/ML landscape. For regulatory experts, a thorough understanding…
The Taiwan Food and Drug Administration (TFDA) is a rigorous regulatory authority that oversees the safety, efficacy, and quality of medical devices in Taiwan. While similar to other regulatory bodies, the TFDA has its unique requirements and processes that can pose significant challenges for medical device companies. Key Challenges and Solutions Complex Regulatory Framework: Solution:…
Health Canada’s Health Forward initiative marks a significant step forward for the medical device industry in Canada. This initiative aims to accelerate the development and market access of life-saving medical technologies by prioritizing efficiency, innovation, and patient safety. Key Benefits of Health Forward for MedTech Accelerated Time-to-Market: Streamlined review processes and risk-based approaches will significantly…
Understanding INVIMA: Colombia’s Regulatory Authority As the MedTech sector evolves rapidly, regulatory affairs specialists are instrumental in guiding companies through compliance complexities. A solid understanding of the National Institute for Food and Drug Surveillance (INVIMA) is essential for those looking to enter the Colombian market. This blog delves into INVIMA’s recent reforms and their implications…
For many companies with CE-marked products under the Medical Device Directive (MDD) or In Vitro Diagnostic Directive (IVDD), the transition to the new Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) has become a challenging and costly process. What once was a straightforward regulatory pathway now feels like navigating a maze, with stricter…
